Long-term immunity after BNT162b2 mRNA COVID-19 vaccination in pediatric patients with cancer
K. L. Juliëtte Schmidt(Princess Máxima Center), Wim J. E. Tissing(University Medical Center Groningen), Marta Fiocco(Leiden University Medical Center), Louis Bont(University Medical Center Utrecht), Noël M M Dautzenberg(Princess Máxima Center), Rob van Binnendijk(National Institute for Public Health and the Environment), Caroline A. Lindemans(University Medical Center Utrecht), Stefan Nierkens(Utrecht University), Gaby Smits(National Institute for Public Health and the Environment), Peter M. Hoogerbrugge(Helios Klinikum Emil von Behring), Noortje R. Severeijns(Princess Máxima Center)
Cited by 3
Related Papers
Gut microbiome–derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease
|Nature Immunology|2016|727